BST2/CD317 counteracts human coronavirus 229E productive infection by tethering virions at the cell surface

Virology

Volumn 449, Issue , 2014, Pages 287-296

  Wang, Shiu Mei ^a,b   Huang, Kuo Jung ^a   Wang, Chin Tien ^a,b  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

BST2; CD317; Human coronavirus 229E; Tetherin; Virus budding

Indexed keywords

ANTIVIRUS AGENT; BONE MARROW STROMAL ANTIGEN 2; UNCLASSIFIED DRUG;

ANTIVIRAL ACTIVITY; ARTICLE; CELL COMPARTMENTALIZATION; CELL MEMBRANE; CELL SURFACE; CONTROLLED STUDY; CORONAVIRUS; CORONAVIRUS INFECTION; ENDOPLASMIC RETICULUM; GOLGI COMPLEX; HUMAN; HUMAN CELL; HUMAN CORONAVIRUS 229E; NONHUMAN; PRIORITY JOURNAL; PROGENY; VIRION; VIRUS CELL INTERACTION; VIRUS ENVELOPE; VIRUS RELEASE; VIRUS STRAIN;

HUMAN CORONAVIRUS 229E;

BST2; CD317; HUMAN CORONAVIRUS 229E; TETHERIN; VIRUS BUDDING;

ANTIGENS, CD; CELL LINE; CELL MEMBRANE; CORONAVIRUS 229E, HUMAN; CORONAVIRUS INFECTIONS; GPI-LINKED PROTEINS; HUMANS; VIRION; VIRUS RELEASE;

EID: 84890282668     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2013.11.030     Document Type: Article

References (44)

1. Bampi C., Rasga L., Roux L. Antagonism to human BST-2/tetherin by Sendai virus glycoproteins. J. Gen. Virol. 2013, 94:1211-1219.
2. Dafa-Berger A., Kuzmina A., Fassler M., Yitzhak-Asraf H., Shemer-Avni Y., Taube R. Modulation of hepatitis C virus release by the interferon-induced protein BST-2/tetherin. Virology 2012, 428:98-111.
3. Drosten C., Gunther S., Preiser W., Werf S., Brodt H.R., Becker S., Rabenau H., Panning M., Kolesnikova L., Fouchier R.A. Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N. Engl. J. Med. 2003, 348:1967-1976.
4. Erikson E., Adam T., Schmidt S., Lehmann-Koch J., Over B., Goffinet C., Harter C., Bekeredjian-Ding I., Sertel S., Lasitschka F., Keppler O.T. In vivo expression profile of the antiviral restriction factor and tumor-targeting antigen CD317/BST-2/HM1.24/tetherin in humans. Proc. Nat. Acad. Sci. U.S.A 2011, 108:13688-13693.
5. Garbino J., Crespo S., Aubert J.-D., Rochat T., Ninet B., Deffernez C., Wunderli W., Pache J.-C., Soccal P.M., Kaiser L. A prospective hospital-based study of the clinical impact of non-severe acute respiratory syndrome (Non-SARS)-related human coronavirus infection. Clin. Infect. Dis. 2006, 43:1009-1015.
6. Goffinet C., Schmidt S., Kern C., Oberbremer L., Keppler O.T. Endogenous CD317/Tetherin limits replication of HIV-1 and murine leukemia virus in rodent cells and is resistant to antagonists from primate viruses. J. Virol. 2010, 84:11374-11384.
7. Gupta R.K., Mlcochova P., Pelchen-Matthews A., Petit S.J., Mattiuzzo G., Pillay D., Takeuchi Y., Marsh M., Towers G.J. Simian immunodeficiency virus envelope glycoprotein counteracts tetherin/BST-2/CD317 by intracellular sequestration. Proc. Nat. Acad. Sci. U.S.A 2009, 106:20889-20894.
8. Habermann A., Krijnse-Locker J., Oberwinkler H., Eckhardt M., Homann S., Andrew A., Strebel K., Kräusslich H.-G. CD317/Tetherin is enriched in the HIV-1 envelope and downregulated from the plasma membrane upon virus infection. J. Virol. 2010, 84:4646-4658.
9. Holmes K.V. SARS coronavirus: a new challenge for prevention and therapy. J. Clin. Invest. 2003, 111:1605-1609.
10. Hunter, E., 2001. Virus assembly. In: Knipe, D.M., Howley, P.M. (Eds.), Fundamental Virology, fourth ed.
11. Jia B., Serra-Moreno R., Neidermyer W., Rahmberg A., Mackey J., Fofana I.B., Johnson W.E., Westmoreland S., Evans D.T. Species-specific activity of SIV Nef and HIV-1 Vpu in overcoming restriction by Tetherin/BST2. PLoS Pathog. 2009, 5:e1000429.
12. Jones D.M., McLauchlan J. Hepatitis C virus: assembly and release of virus particles. J. Biol. Chem. 2010, 285:22733-22739.
13. Jouvenet N., Neil S.J., Zhadina M., Zang T., Kratovac Z., Lee Y., McNatt M., Hatziioannou T., Bieniasz P.D. Broad-spectrum inhibition of retroviral and filoviral particle release by tetherin. J. Virol. 2009, 83:1837-1844.
14. Kaletsky R.L., Francica J.R., Agrawal-Gamse C., Bates P. Tetherin-mediated restriction of filovirus budding is antagonized by the Ebola glycoprotein. Proc. Nat. Acad. Sci. U.S.A 2009, 106:2886-2891.
15. Kupzig S., Korolchuk V., Rollason R., Sugden A., Wilde A., Banting G. Bst-2/HM1.24 is a raft-associated apical membrane protein with an unusual topology. Traffic 2003, 4:694-709.
16. Le Tortorec A., Neil S.J.D. Antagonism to and intracellular sequestration of human tetherin by the human immunodeficiency virus type 2 envelope glycoprotein. J. Virol. 2009, 83:11966-11978.
17. Le Tortorec A., Willey S., Neil S.J.D. Antiviral inhibition of enveloped virus release by Tetherin/BST-2: action and counteraction. Viruses 2011, 3:520-540.
18. Mangeat B., Cavagliotti L., Lehmann M., Gers-Huber G., Kaur I., Thomas Y., Kaiser L., Piguet V. Influenza virus partially counteracts restriction imposed by Tetherin/BST-2. J. Biol. Chem. 2012, 287:22015-22029.
19. Mansouri M., Viswanathan K., Douglas J.L., Hines J., Gustin J., Moses A.V., Fruh K. Molecular mechanism of BST2/tetherin downregulation by K5/MIR2 of Kaposi's sarcoma-associated herpesvirus. J. Virol. 2009, 83:9672-9681.
20. Marra M.A., Jones S.J.M., Astell C.R., Holt R.A., Brooks-Wilson A., Butterfield Y.S.N., Khattra J., Asano J.K., Barber S.A., Chan S.Y., Cloutier A., Coughlin S.M., Freeman D., Girn N., Griffith O.L., Leach S.R., Mayo M., McDonald H., Montgomery S.B., Pandoh P.K., Petrescu A.S., Robertson A.G., Schein J.E., Siddiqui A., Smailus D.E., Stott J.M., Yang G.S., Plummer F., Andonov A., Artsob H., Bastien N., Bernard K., Booth T.F., Bowness D., Czub M., Drebot M., Fernando L., Flick R., Garbutt M., Gray M., Grolla A., Jones S., Feldmann H., Meyers A., Kabani A., Li Y., Normand S., Stroher U., Tipples G.A., Tyler S., Vogrig R., Ward D., Watson B., Brunham R.C., Krajden M., Petric M., Skowronski D.M., Upton C., Roper R.L. The genome sequence of the SARS-associated coronavirus. Science 2003, 300:1399-1404.
21. Masters P.S. The molecular biology of coronaviruses. Adv. Virus Res. 2006, 66:193-292.
22. Mettenleiter T.C. Herpesvirus assembly and egress. J. Virol. 2002, 76:1537-1547.
23. Miyagi E., Andrew A.J., Kao S., Strebel K. Vpu enhances HIV-1 virus release in the absence of Bst-2 cell surface down-modulation and intracellular depletion. Proc. Nat. Acad. Sci. U.S.A 2009, 106:2868-2873.
24. Narayanan K., Huang C., Lokugamage K., Kamitani W., Ikegami T., Tseng C.-T.K., Makino S. Severe acute respiratory syndrome coronavirus nsp1 suppresses host gene expression, including that of type I interferon, in infected cells. J. Virol. 2008, 82:4471-4479.
25. Neil S.J., Zang T., Bieniasz P.D. Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu. Nature 2008, 451:425-430.
26. Neil S.J.D., Eastman S.W., Jouvenet N., Bieniasz P.D. HIV-1 Vpu promotes release and prevents endocytosis of nascent retrovirus particles from the plasma membrane. PLoS Pathog. 2006, 2:e39.
27. Neil S.J.D., Sandrin V., Sundquist W.I., Bieniasz P.D. An interferon-α-induced tethering mechanism inhibits HIV-1 and ebola virus particle release but is counteracted by the HIV-1 Vpu protein. Cell Host Microbe 2007, 2:193-203.
28. Pardieu C., Vigan R.l., Wilson S.J., Calvi A., Zang T., Bieniasz P., Kellam P., Towers G.J., Neil S.J.D. The RING-CH Ligase K5 antagonizes restriction of KSHV and HIV-1 particle release by mediating ubiquitin-dependent endosomal degradation of tetherin. PLoS Pathog. 2010, 6:e1000843.
29. Perez-Caballero D., Zang T., Ebrahimi A., McNatt M.W., Gregory D.A., Johnson M.C., Bieniasz P.D. Tetherin inhibits HIV-1 release by directly tethering virions to cells. Cell 2009, 139:499-511.
30. Perlman S., Netland J. Coronaviruses post-SARS: update on replication and pathogenesis. Nat. Rev. Micro 2009, 7:439-450.
31. Radoshitzky S.R., Dong L., Chi X., Clester J.C., Retterer C., Spurgers K., Kuhn J.H., Sandwick S., Ruthel G., Kota K., Boltz D., Warren T., Kranzusch P.J., Whelan S.P.J., Bavari S. Infectious lassa virus, but not filoviruses, is restricted by BST-2/Tetherin. J. Virol. 2010, 84:10569-10580.
32. Randall R.E., Goodbourn S. Interferons and viruses: an interplay between induction, signalling, antiviral responses and virus countermeasures. J. Gen. Virol. 2008, 89:1-47.
33. Rota P.A., Oberste M.S., Monroe S.S., Nix W.A., Campagnoli R., Icenogle J.P., PeAaranda S., Bankamp B., Maher K., Chen M.-h., Tong S., Tamin A., Lowe L., Frace M., DeRisi J.L., Chen Q., Wang D., Erdman D.D., Peret T.C.T., Burns C., Ksiazek T.G., Rollin P.E., Sanchez A., Liffick S., Holloway B., Limor J., McCaustland K., Olsen-Rasmussen M., Fouchier R., GA?nther S., Osterhaus A.D.M.E., Drosten C., Pallansch M.A., Anderson L.J., Bellini W.J. Characterization of a novel coronavirus associated with severe acute respiratory syndrome. Science 2003, 300:1394-1399.
34. Sadler A.J., Williams B.R.G. Interferon-inducible antiviral effectors. Nat. Rev. Immunol. 2008, 8:559-568.
35. Sakuma T., Noda T., Urata S., Kawaoka Y., Yasuda J. Inhibition of lassa and marburg virus production by tetherin. J. Virol. 2009, 83:2382-2385.
36. Sambrook J., Russell D.W. Molecular Cloning: A Laboratory Manual 2001, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y. third ed.
37. Sauter D., Specht A., Kirchhoff F. Tetherin: holding on and letting go. Cell 2010, 141:392-398.
38. Swiecki M., Omattage N.S., Brett T.J. BST-2/tetherin: structural biology, viral antagonism, and immunobiology of a potent host antiviral factor. Mol. Immunol. 2013, 54:132-139.
39. Van Damme N., Goff D., Katsura C., Jorgenson R.L., Mitchell R., Johnson M.C., Stephens E.B., Guatelli J. The interferon-induced protein BST-2 restricts HIV-1 release and is downregulated from the cell surface by the viral Vpu protein. Cell Host Microbe 2008, 3:245-252.
40. Watanabe R., Leser G.P., Lamb R.A. Influenza virus is not restricted by tetherin whereas influenza VLP production is restricted by tetherin. Virology 2011, 417:50-56.
41. Yondola M.A., Fernandes F., Belicha-Villanueva A., Uccelini M., Gao Q., Carter C., Palese P. Budding capability of the influenza virus neuraminidase can be modulated by tetherin. J. Virol. 2011, 85:2480-2491.
42. Zaki A.M., van Boheemen S., Bestebroer T.M., Osterhaus A.D.M.E., Fouchier R.A.M. Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N. Engl. J. Med. 2012, 367:1814-1820.
43. Zhang F., Wilson S.J., Landford W.C., Virgen B., Gregory D., Johnson M.C., Munch J., Kirchhoff F., Bieniasz P.D., Hatziioannou T. Nef proteins from simian immunodeficiency viruses are tetherin antagonists. Cell Host Microbe 2009, 6:54-67.
44. Zlateva K., Coenjaerts F.J., Crusio K., Lammens C., Leus F., Viveen M., Ieven M., Spaan W.M., Claas E.J., Gorbalenya A. No novel coronaviruses identified in a large collection of human nasopharyngeal specimens using family-wide CODEHOP-based primers. Arch. Virol. 2013, 158:251-255.